WNBA Star Sentenced to 9 Years for Marijuana Possession in Russia

Dec.09.2022
WNBA Star Sentenced to 9 Years for Marijuana Possession in Russia
WNBA star Brittney Griner sentenced to nine years in Russian prison for possession of marijuana in her luggage.

According to Russian authorities, WNBA star Brittney Griner was found with a marijuana electronic pod in her carry-on luggage at a Moscow airport in February of this year. As a result, she has been sentenced to nine years in a Russian prison.


The two-time Olympic basketball champion and member of the US national team was arrested after being found in possession of a container of cannabis derivative oil.


Before announcing the verdict, Griner told the court that she inadvertently brought an electronic cigarette pod containing cannabis oil with her when she flew to Moscow to play basketball in Yekaterinburg in February.


The legality of possessing marijuana products varies by state and jurisdiction, which may impact the experiences of individuals traveling with such products.


In the United States, marijuana remains illegal under federal law.


Although cannabis is legal for adults in some states in the United States, it is still illegal according to federal law. It is not recommended to transport it across borders.


THC is the primary psychoactive substance in marijuana, while CBD is a non-psychoactive component of cannabis that is typically sold in other products such as lotions and supplements.


Certain cannabis-infused products, including CBD oil, are considered illegal at the federal level if they contain more than 0.3% delta-9-tetrahydrocannabinol (THC) by dry weight.


It is currently unclear whether the ammunition canister carried by Griner, as mentioned by Russian officials, contains either one or both of CBD or THC.


In January 2021, the organization reported that the US Food and Drug Administration has only approved one cannabis-derived product, Epidiolex, which contains purified CBD, as well as three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). These can only be obtained with a prescription from a licensed healthcare provider.


TSA Does Not Search for Drugs


Officials from the Transport Safety Management Bureau are required to report suspected illegal activities to local, state, or federal authorities, but they will not conduct searches for illegal drugs during screenings.


According to the website, TSA security personnel do not search for marijuana or other illegal drugs, but if any illegal substance is found during the security screening process, the TSA will report it to law enforcement officials.


The TSA has stated that their dogs cannot detect marijuana. However, in an Instagram post, they reiterated that in the screening process, if a substance or product infused with marijuana is found, even for medical use, law enforcement will be notified.


Carrying marijuana products while traveling abroad.


There are no specific guidelines for traveling internationally with cannabis products, but if a certain product is illegal in a particular country or region, carrying it while traveling could have consequences.


For instance, while marijuana is legal for adults in Canada, the government's tourism website states that transporting these products across the Canadian border, regardless of the amount of medical authorization, is illegal.


According to the website, this applies even if the person is traveling to and from a place where marijuana is decriminalized. The consequences of traveling with cannabis products may include being denied entry into a particular country or region.


According to the Canadian government website, "if you have used cannabis or any substance prohibited by local law in the past, you may be denied entry to your destination country." "You may also be refused entry to other countries in the future.


In recent years, Russia has arrested two women for similar reasons.


In Russia, cannabis for recreational or medicinal purposes is illegal.


In April 2019, an Israeli-American woman was arrested at Moscow airport while traveling from India to Israel and found with 9 grams of cannabis in her luggage, according to BBC News.


A 26-year-old woman, Naama Issachar, was sentenced to more than 7 years in prison for drug trafficking. According to the British Broadcasting Corporation, Russian President Vladimir Putin pardoned her in January 2020 before the visit of then-Israeli Prime Minister Benjamin Netanyahu to Moscow.


According to a report by The Moscow Times in September 2019, a film student from New York was charged with possession of drugs in St. Petersburg for allegedly bringing medical marijuana into the country.


2FIRSTS will continue to track and report on this topic, with updates available on the "2FIRSTS APP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
According to convenience retail publication CStore Decisions, U.S. convenience store tobacco categories are undergoing a structural shift. Based on Circana OmniMarket Total U.S. Convenience data for the 52 weeks ending June 14, 2026, cigarettes remained the largest category with $50.8 billion in sales, but unit sales declined 5.3%. Electronic smoking devices and vaping products also declined, while modern oral nicotine products continued to grow, with nicotine pouch sales rising 29% in dollars and 17% in units. Retailers said changing consumer preferences are reshaping tobacco product assortments at convenience stores.
Regulations
Aug.07
2Firsts Data | China’s Vape Exports Rise 3.1% in H1 2026 as 6-Methyl Nicotine-Related Products Surge 65.2%
2Firsts Data | China’s Vape Exports Rise 3.1% in H1 2026 as 6-Methyl Nicotine-Related Products Surge 65.2%
China’s vape exports showed resilience in the first half of 2026 after a short-term shock from China’s export rebate adjustment. But customs data points to more than a simple recovery: the structure of growth is changing. Vaping devices and atomization hardware emerged as the strongest growth driver, while nicotine-containing vaping products remained broadly stable. Meanwhile, nicotine substitute-related products represented by 6-methyl nicotine expanded rapidly, becoming a new category to watch for both industry and regulators. After the U.S. market went through a cycle of shortages, replenishment and inventory rebuilding in 2025, China’s vape supply chain is entering a new phase of reallocation.
Special Report
Jul.20
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
BAT Rothmans says it previously considered exiting South Korea's vaping market because of competitive pressure from unregulated products, but is now reassessing conditions following changes to the country's nicotine regulatory framework. Vuse and other BAT vaping products remain available through existing distribution channels. The statement followed a South Korean media report that interpreted BAT's broader withdrawal from selected Vapour markets as a full exit from South Korea. Meanwhile, Philip Morris International launched VEEV inPRIME in the country in June and began expanding distribution to around 14,000 convenience stores and other retail channels in July. The contrasting moves highlight differing investment strategies as South Korea's regulated vaping market evolves.
Aug.14
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
ITC Infotech has expanded its multi-year strategic technology partnership with British American Tobacco (BAT), providing technology services across Poland, Romania and India while continuing to support BAT's newly launched Future Capabilities Centre in India and existing technology hubs in Malaysia and Mexico. The companies said the agreement will focus on AI-enabled innovation, technology capability building and greater operational efficiency. The partnership also aligns with BAT's broader Fit2Win transformation programme, under which the group is expanding the use of external technology and business-services partners to simplify its global operating model.
Aug.13
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27